{"ticker": {"uuid": "fe76b9a5-9d69-445d-a49e-e107f61ffc89", "symbol": "VRTX", "name": "Vertex Pharmaceuticals Incorporated", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_AFBVV95cUxPaDJTZGVSckVJSG5IU1lXSTUxTUdVZlljZmVpdlEwV3R5akVqdmZmU044Z1M4UEJDM3Y5em5VcGJ1eGhvamxDWnktcnQ2eXRBbDhPdHJocU9xbEwyZjRfYnJaYlVTZ0ZvemxXSURYbFRWWldMb2RWYndOXzlxX2p2Y21YaEpuMXJjbUZSY2pqVDctVTloWlU5cDhVb3RiTEwzTVhnS25mZGhrUElzVXNwMk5GbDI1T2tpVFBYRjFqbTF3Rk9nNU1fLUp6TEJhMERWQ1dHVWtJZTRtNkdXd1dPSVJWYTRMOUhYX3Itd0dlUTNqVC1CWWRpNDV5S1o?oc=5", "source_name": "ChartMill", "published_at": "2026-07-21T12:20:29+00:00", "published_display": "21 Jul 2026 12:20", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-21T00:47:15+00:00", "published_display": "21 Jul 2026 00:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPUWZJazIzUmJsTkhtT3hUbGN2QWhONy1hUWhpWTF5SWVkQUtyOFFtZWNRSlljRy1RbXRCa0RNUnY5dGxZM19OcUxMZVczRUVSamlQOFc3UU5mSEJlTHBYSnAxZWhpYWRzVDI1N3pzTUc4cngwdDZKeERRRGJZSjhFSTF2M1hrSXFsekNtQ2VkVTBBVVc2ZVFmeWMwTk94S1hwT0hyaWpn?oc=5", "source_name": "Market source", "published_at": "2026-07-20T22:00:06+00:00", "published_display": "20 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Pediatric Casgevy Expansion and Canadian ALYFTREK Talks Change Vertex Pharmaceuticals' (VRTX) Narrative?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T03:47:09+00:00", "published_display": "18 Jul 2026 03:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) declines more than market: Some information for investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNVzg2WTh3ZTZ2bGxrallacVlVM0tNQTdtSURydFdtNzdoOTFmTGdrM1N3QTBESXI3azMycDkwTzhuMWk5aC1MN0VSOC1MZ3BNYWlOR2J3TnNWeFZ1QVoxQUVQNjZ0ckFzRmRlRWYxeUFIRUpucFBzbjV3alNIM0V5QzdIWDVBWFFWdnBfQndPRThGbFZiSWdTd2lQUjlvQXdjeVFKb2NtY1ZjVXZxQ2REMzlzUVc2M1VkYWJGZU1FUWpBampYQU5lSzVJdUpDX2NX?oc=5", "source_name": "MSN", "published_at": "2026-07-16T13:56:05+00:00", "published_display": "16 Jul 2026 13:56", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOSDV4a01ZcnR5VndFbmVYc0t5clpyeTFZRzk1cG5hdDV2VEFyMjJRQkN6cGlKNWEyWjhwb2F5SVhpU2NYMjYxZnFUZGhWSW1JM2JyQ1YwT2dNTmFpVzlaWXlpRDRuQzlqVExlVzZtWC1DSVJXUDhSUFMyaVdVTXRNcy1Kd3QtNHdoNWhobXh5WVNYc3hpWDY4RmZfaTlleURIYUJyVkhfVV9KZ1VJZjFCTmc3YVM?oc=5", "source_name": "Market source", "published_at": "2026-07-16T13:00:03+00:00", "published_display": "16 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock 6-Day Losing Spree: Stock Falls 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxObTFRckp5QXl4WlhtOGRUZGpfMWZNZjlSdngxOEEtdFA2T3NFSE0zVXE4MWR6dU1PQWlLc3IzQ3JSbFFSWkVRNlpjOG04ay11d1Y0WHo4SUhiQXhoejgwdVR4bWVzNFJ1Z0NOQW9pS1VCTkpaMmMyeWllcUdBMHBRbF9VOEhGZ1FVWVBBMllsT09EVnFGbTZ4ODY4SkUxMkJKYUpNemN6QTN1U1R4a3BlUU40YS1CSTFRS19iTTNxaElVUkhiYkk1S2hzZktiZw?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T14:27:41+00:00", "published_display": "15 Jul 2026 14:27", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Slides 10% Over 6 Straight Down Days", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPbDVXM0xSMWZVMGozVFQwOE5idmx4Z1ZZckFIQXBKMTZVRDFPei1oTUJOZkJCbjRoZzJGczFfdGFTMzRvR0NSa2R1eXpyX29CR1dZWFc4XzZmYnNGbWhWLWFIVkdEUGgtZUdIaUxmOUl3UlllQnNYcHROUmtPeTZTSjJZcm02V1ZYX0JxZHlOSmhXeEZBYTVnSWhVOUMyUXotQU1kVHBSTndTZElOV0tnNmFFWVY4aFIwbXM5b2pTY3hBOUE?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T13:32:34+00:00", "published_display": "15 Jul 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNVHJ2c1IzQVpRYks4U2VPUkJERVBNU3pEcnYwRG5UdGMzUjh3Wi1sX21saDQ5aUtjV25CRy15WEd0QTQ4NzZxSjdHVUZBUWZMZDQyQ2g0eWtVSkF0Ui1aWVdlMGt6UW1ZU21oaUNIWmdBcldHWkNySXgxbWJDWmVLdXJuYzlnMjRxUVpsX3Vzc0NEdjdiVnFYVFF3?oc=5", "source_name": "AOL.com", "published_at": "2026-07-13T19:08:46+00:00", "published_display": "13 Jul 2026 19:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals just made a $10 billion move. Is the stock a buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNU25vMzJHUWF4N04wazN3aTlkYVVoXzlwVWhYUFdxWEduLThYdlByRUx1MEtoU3dOMzRJd3FXSnlZMEQ3bkxTYWpndmJMRTNuTGNQTTNlR3dfUWJzM0pELWhMZTJCV2h5WXNmclpVME5jeHppQm5razU4OEFSZmFGRktwT2FVLWZVMXZ5RmotcnI5R2NreHZjeDlQVU93M05FX0R2TzRWSGc1bjN3eFplVGVWOFFmcGFmNnRxdg?oc=5", "source_name": "MSN", "published_at": "2026-07-10T09:56:04+00:00", "published_display": "10 Jul 2026 09:56", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNTk9HVDlSOUNLT1UtdHJneGNsa0JNaURYMFBZSDFTMGJlV19vb2NlUzcwTzFUbHIxMWhhdUhqSUs0b2prdUdTUTdGZ3hUQkt4Y09hMC1DMHVGMENIX1E4MVFMUjVSUllMOVJQRUtQdTM1ejZJNldGVkhaRjRsQVR4dWRodGJkM09xNzk2WmVrZ3h3ZXc?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQR2RDNU9TQWFnd2ZndjVkZGtzcHhMc0lhS2FqN1UxaWQxRm5zanR3SE5NUFJhSFQ2T0g5cFNabzJGUHJxZHloZFM3a0FCVXVaRF92Ukh6Z2dOdUlDeGpQZkswS3U2VUFteUxZcU1xYlJoSGFWVVB2RHZHby1pY2VyVFRDajVjN05RN0FyeG1lXzYycGJPcVBqWHZqZXJpQ1RUTlQyclRJNElLNENWQ2E1Ul9jdw?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to buy Crinetics for $10 billion in rare-diseases push", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOX3N1NDFzcDNMSmVSODY1SEJGRm51Sl96QmtwWV9zMHA3RUZTRVlDenhJaG01alZQSU5KZUNWV2NFMFp6c0U5Xy1aZFZ2UXVmNWFGNk1HR1NMcGpJWHVpQjVtQWV2Z0FqMldWWHFwMlA2cHh1eDBtT19sem9BZ1ljblQta09WbWdBcjFzX3JVY2h2WlFsQ1VZ?oc=5", "source_name": "Reuters", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeUVTekQtYjFqODVQTUpmWnpTSlBZT3lEWmhDVjhFZEc2dDctNjZXZ0MySENpa01tQS1CLVgtNTB6cGRWNWIyME9BOGhpRGlDYWF2bWYxRHlnbEtmN3FuZUlVT2c5NVhqZlNjSUlVTWxvYUFCX29xUU4wemRLYkhnOFhnOFhBVmJvYVk5Q1VfaW5KLWN0bElGRG9fdmlXZ1VpNjRqR3NTaWlqQVRCOHdLRkUzdTlLblNPOENJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYUJCRHpLdzhuNmcxVnZLVUVLSWc3U0JqNVpuOHNLbmMwZmE4NG1Yb2M3Xy1CMUk0T1hjM3VmeEpTV2xJMmVTX1BiMk5VOG93WS1TeG1fQ2NlYk44cHBfQzFTZ2U1UERQSHlYU2lDeG1SQzNMOVJyazRvSDdVZ0JuMUtMbGdSU2xVXzBuRjdDN2dwaUd5Y1pXdVQwZ3h2alFHb0k3ZE9CVUM?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock After Strong Multi\u2011Year Run Is The Price Still Reasonable", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVW9halB2RDE0V056SmV5NEd0Wl95ekI0eWM3QzVsckpLQ2RMWkF3SWRMSUFmMlViUHBObGVobXhwYW5CWU42WG5NUG45WHhDNGEzcHlheG1hM1lZWkpTOUs3UFFmUHdDOUw2V2tEV0N4YnlMY0d0cmswalo4WnZzTWlVZGd6ZmdyeW5WSXZJRFplSFkyRnREQnlJaVN4MFA3WS1uWU55blg?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPNzJydi1RUXhvaVExQVVJWnhpYjEyb3NOVHJheExOYmsyLU5famxjRnRWdS1TSDJLWjZNUmtEa3RLNkZxaGVtYWNPSmFLSFJnNktJWDVHSk9DVFlmVVdLLWRmWHdiR19LZXpWZm9MWlU4VkVOOGp0QktVX3ZmdWtiZ25BSS05SzVqaEtacm9fSGI4bzcyMVN0RTNIWWFCaTA?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQeUVIWEVWTFVLNWlzMWNvNjgzWUI4dEl6QUxLX203eER6UlF2SXBUSGR0WGRBUTh4ZjZEaW4wVFZyMElqZXVWbGlmd2hPWkc0WjNVMFVhcTdtbU1BU2VUMmdDOWQxeXkyMV9feWlhV2NKV0x5eEtzU0NSeUZmNFhqaWIxUkoxdVQ0YXN3VWtZRXZEWDk3eXI4ZjZueEtHc190NUlXTk13LVFNZ1gzUDdPMzAzOEprWWZ1WDdTNWEwTTBWS3Fu?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQY2F4dS1iZUJuTE1VNlVHQ1paVHg1U2VRUG5vcTZFdmFSdXB0Z0RQdVlkUXdxNzhYaGIzOVNhVWctVnJpUG1ZZFNydFkwUGo4Si1UdmtSaFNXb1RuQnNFdU1vekFEU3pGYVhwUnlvY01zdmJ6dXZrZ1Bia3ZDRHI4NGRCN1ZudnRWMkVYMzhleWp5OHpmdjJOdkRhVDJKYW9VMXE1dDV6dVhJQzR4aXI4?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPS0tESHdtOGhOSUhoZ3VTUUtOSXY0S3hLNzdNYmZMcmpMSTJVQkNpZDk2RzJDTEJJckdoNFZkR29zVGI3Vmh5OFV5cU5QNV80MFc1cjhyTlhKcFB2UG9MbkRoR2xZamR1NkNBQmhsRFRDYkQ1U21jLWpoMWE3bmxxT3BOY05vdjhWWmF0UXNGdjEyZE9TcjJYTlpfMnJOa2sxalJPT21rYWQ2d1JwZ0ZDa3pR?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPNWgxZmFPcUY5cHVqUjNNZ2pHVDE5Y0FJdnZBYmxLQlBKZnlGMC10UExaNUdzc0U1cWQxbmVKa1gzekFIazRWN3RsTTFKTGU0bURmV0dSbFVvVllDQS1mNnprR3lGQUxEQnNLR1FPWWhVdDZOVE9fRWZ4THNNQzdoUnk3ajg4amROUE9oUXBzWDFRUjg5N3c5ZzZ4S1NoeEkyNFY1OWVkQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR3pDcWtZWjd1c1dwOTlpY0cwZUJkYWJCLVBlS0o0Y0ctOE5ENUh5b2dicHhSdGxmR19XblF0UzgtQkVaOTM1ZnFGcl85bS1DMGYtRzI5bTZwMVByeWs5YmVYcVR5elM4cjVHVmQ3aHpHWlRScUFKRWxtUVl3c3lhcFpndWt5MlVJY0xpdUpiRkNsUk84U3kyVHZLT2tPT3F5am40bE9YWFA?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdXIxTVd1ZHVTWmF3Tk55OHVsWW1aa204VXlzNkZuQWpfaGJkRjhlRncxRkZUb2ctYlJLV1hiY0QxYlFzMW9OS1A1WjlzaDhrclNGZUtXZ1gyRVNaTDRkUi1PcjBnVTBiVnpFaGdQWVBDRjh6b2FNZVNHcndESkNydFByQWVVTE9yU2RoUnZMSTFVdGdNakt0TlpoNXg5SnRDaWZSMUprbw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals Successfully Diversifying Beyond Cystic Fibrosis", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQQ21BWXcycGhEUHoxYXBOcWk0eWJTYVlWcHpYd2dEMHZqaEJ4R1ZTM0RYQ2ZmOWRSUHlGNC15U3dRSXQ3VjA0V1dBTW5sVE92MmFEZEdwelRvREhfalpLVjI2YnNMUlU4eUJGYVhTNF9DMi1yX3RfME9CVkxkenViWHJvbWs0QUNmbnRjWVhMZjZzelRzQVhGV05EdHBkVzNPLVhFSDBYM1JGU2pGcVE?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-27T21:19:59+00:00", "published_display": "27 Feb 2026 21:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMUxjTEUwRWhBQmxlYXlaVTRqY1NuMEFpX0pFR3ltQmVnVXUwdEtFbEhoUkswZ1NoYW5QbVhSUTM3anpxclI5d2NzSlIwSjg1a0d6cGdOTUg4ZEF3U0IyN0NtLUg2eGxucldIajMzN1lIaFFmNnprWlFYZWRSdjVpaHVPYW0xOWhUdmhv?oc=5", "source_name": "Time Magazine", "published_at": "2026-01-07T17:42:38+00:00", "published_display": "07 Jan 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex\u2019s Journavx successor culled in acute pain after falling short in Phase II", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNTlp6QlZMM09CSTNhd1FHUXZocTc1NnJjbEllbkNjb2VDRlN0dV91Z2ZJUHc3MUt5aUt6TjZ2eVF5bmhGTi1JMVR6a0xVVlpTZmJ0TjZDRUVQRnN5S0F3RDJ5SVY3Q3JTRFdCbUVJelk2MzNkRDVIbExYSjdjN1hmSy1GaGl1dFpFT3hWalZKQjBaOVA4SHZR?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxOaGw3ZzNKZThYbDM5LURlSXlaYTRsSG01Z25CS2R3TE16ZEViR3ZMUjZwY1ZBREhpc1poaUlmNGlsbXV6alZLZEQ0U2l3WWdQdlFXOEE4N21ialRuN1d5VWlnMzRwVkt4NlNaU2NJdkhQWlIxWElBMXMyb0JhTTJiX0lwalZNQklCYzRPY3ZpNm1VODZpT1BCY1FtQzNhRXNyUENDaWtOQ0JROEdWdFBGVEpvTFFZeFZLai1QR2swUzQtLXZMOVNpTmxRajdpVFhybVViVnpDd2F2dmkxY0xtZXJmV29sNUlFWWQtX1kyV1V4b2d6OGI1V0RFZ3hjQkZPRTBuVDg4SjBzUW04M1pjREVYX190STdrbllwbWVObDMxU3c?oc=5", "source_name": "PR Newswire Canada", "published_at": "2025-07-22T07:00:00+00:00", "published_display": "22 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Non Opioid Drug Painkiller Stock Fda Journavx", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQeERmRVBhdm4xa1I2cHZmeUJkeERUUWxodE1HZ1EyLU1yM08zdUlEV2x2WWNaZjN2VUtIdG12YzVoUzIyWGJqSl90cmllTlZadDMwcjBjODhCWnpESzBORGdmZUVfMUZTR09WMmRNNEI5cFRJQUdsQ0daZEdwemZPbFpkbU4?oc=5", "source_name": "qz.com", "published_at": "2025-01-31T08:00:00+00:00", "published_display": "31 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prediction: Vertex Pharmaceuticals (VRTX) Could Be The Next Stock Split Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNZ0JCcndyUmhwZTJNVGNNU0pjdkJiU1FId1o1VzZnQXBwVHpYQnBTY3lWX0RQeFU5TWdhYXZPenQ2Tmx1TXZzVWF4TzR5QmpxZ0VWdDctSWx0aGFjUXdTdUdKOXU5S3p5TXk1UC1Jek9hQnJJM2VQLUlfMzZ6eUQwZnU0OGlzVlZyNjRRaXZLSkRBblVDWDhoTXJzRFlLOTJIZV9mZVdCNTJMc2xEWF81TG5pSHlRX2h1SFE?oc=5", "source_name": "24/7 Wall St.", "published_at": "2024-10-31T07:00:00+00:00", "published_display": "31 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_AFBVV95cUxPaDJTZGVSckVJSG5IU1lXSTUxTUdVZlljZmVpdlEwV3R5akVqdmZmU044Z1M4UEJDM3Y5em5VcGJ1eGhvamxDWnktcnQ2eXRBbDhPdHJocU9xbEwyZjRfYnJaYlVTZ0ZvemxXSURYbFRWWldMb2RWYndOXzlxX2p2Y21YaEpuMXJjbUZSY2pqVDctVTloWlU5cDhVb3RiTEwzTVhnS25mZGhrUElzVXNwMk5GbDI1T2tpVFBYRjFqbTF3Rk9nNU1fLUp6TEJhMERWQ1dHVWtJZTRtNkdXd1dPSVJWYTRMOUhYX3Itd0dlUTNqVC1CWWRpNDV5S1o?oc=5", "source_name": "ChartMill", "published_at": "2026-07-21T12:20:29+00:00", "published_display": "21 Jul 2026 12:20", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-21T00:47:15+00:00", "published_display": "21 Jul 2026 00:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPUWZJazIzUmJsTkhtT3hUbGN2QWhONy1hUWhpWTF5SWVkQUtyOFFtZWNRSlljRy1RbXRCa0RNUnY5dGxZM19OcUxMZVczRUVSamlQOFc3UU5mSEJlTHBYSnAxZWhpYWRzVDI1N3pzTUc4cngwdDZKeERRRGJZSjhFSTF2M1hrSXFsekNtQ2VkVTBBVVc2ZVFmeWMwTk94S1hwT0hyaWpn?oc=5", "source_name": "Market source", "published_at": "2026-07-20T22:00:06+00:00", "published_display": "20 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Pediatric Casgevy Expansion and Canadian ALYFTREK Talks Change Vertex Pharmaceuticals' (VRTX) Narrative?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T03:47:09+00:00", "published_display": "18 Jul 2026 03:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) declines more than market: Some information for investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNVzg2WTh3ZTZ2bGxrallacVlVM0tNQTdtSURydFdtNzdoOTFmTGdrM1N3QTBESXI3azMycDkwTzhuMWk5aC1MN0VSOC1MZ3BNYWlOR2J3TnNWeFZ1QVoxQUVQNjZ0ckFzRmRlRWYxeUFIRUpucFBzbjV3alNIM0V5QzdIWDVBWFFWdnBfQndPRThGbFZiSWdTd2lQUjlvQXdjeVFKb2NtY1ZjVXZxQ2REMzlzUVc2M1VkYWJGZU1FUWpBampYQU5lSzVJdUpDX2NX?oc=5", "source_name": "MSN", "published_at": "2026-07-16T13:56:05+00:00", "published_display": "16 Jul 2026 13:56", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOSDV4a01ZcnR5VndFbmVYc0t5clpyeTFZRzk1cG5hdDV2VEFyMjJRQkN6cGlKNWEyWjhwb2F5SVhpU2NYMjYxZnFUZGhWSW1JM2JyQ1YwT2dNTmFpVzlaWXlpRDRuQzlqVExlVzZtWC1DSVJXUDhSUFMyaVdVTXRNcy1Kd3QtNHdoNWhobXh5WVNYc3hpWDY4RmZfaTlleURIYUJyVkhfVV9KZ1VJZjFCTmc3YVM?oc=5", "source_name": "Market source", "published_at": "2026-07-16T13:00:03+00:00", "published_display": "16 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock 6-Day Losing Spree: Stock Falls 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxObTFRckp5QXl4WlhtOGRUZGpfMWZNZjlSdngxOEEtdFA2T3NFSE0zVXE4MWR6dU1PQWlLc3IzQ3JSbFFSWkVRNlpjOG04ay11d1Y0WHo4SUhiQXhoejgwdVR4bWVzNFJ1Z0NOQW9pS1VCTkpaMmMyeWllcUdBMHBRbF9VOEhGZ1FVWVBBMllsT09EVnFGbTZ4ODY4SkUxMkJKYUpNemN6QTN1U1R4a3BlUU40YS1CSTFRS19iTTNxaElVUkhiYkk1S2hzZktiZw?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T14:27:41+00:00", "published_display": "15 Jul 2026 14:27", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Slides 10% Over 6 Straight Down Days", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPbDVXM0xSMWZVMGozVFQwOE5idmx4Z1ZZckFIQXBKMTZVRDFPei1oTUJOZkJCbjRoZzJGczFfdGFTMzRvR0NSa2R1eXpyX29CR1dZWFc4XzZmYnNGbWhWLWFIVkdEUGgtZUdIaUxmOUl3UlllQnNYcHROUmtPeTZTSjJZcm02V1ZYX0JxZHlOSmhXeEZBYTVnSWhVOUMyUXotQU1kVHBSTndTZElOV0tnNmFFWVY4aFIwbXM5b2pTY3hBOUE?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T13:32:34+00:00", "published_display": "15 Jul 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNVHJ2c1IzQVpRYks4U2VPUkJERVBNU3pEcnYwRG5UdGMzUjh3Wi1sX21saDQ5aUtjV25CRy15WEd0QTQ4NzZxSjdHVUZBUWZMZDQyQ2g0eWtVSkF0Ui1aWVdlMGt6UW1ZU21oaUNIWmdBcldHWkNySXgxbWJDWmVLdXJuYzlnMjRxUVpsX3Vzc0NEdjdiVnFYVFF3?oc=5", "source_name": "AOL.com", "published_at": "2026-07-13T19:08:46+00:00", "published_display": "13 Jul 2026 19:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals just made a $10 billion move. Is the stock a buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNU25vMzJHUWF4N04wazN3aTlkYVVoXzlwVWhYUFdxWEduLThYdlByRUx1MEtoU3dOMzRJd3FXSnlZMEQ3bkxTYWpndmJMRTNuTGNQTTNlR3dfUWJzM0pELWhMZTJCV2h5WXNmclpVME5jeHppQm5razU4OEFSZmFGRktwT2FVLWZVMXZ5RmotcnI5R2NreHZjeDlQVU93M05FX0R2TzRWSGc1bjN3eFplVGVWOFFmcGFmNnRxdg?oc=5", "source_name": "MSN", "published_at": "2026-07-10T09:56:04+00:00", "published_display": "10 Jul 2026 09:56", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNTk9HVDlSOUNLT1UtdHJneGNsa0JNaURYMFBZSDFTMGJlV19vb2NlUzcwTzFUbHIxMWhhdUhqSUs0b2prdUdTUTdGZ3hUQkt4Y09hMC1DMHVGMENIX1E4MVFMUjVSUllMOVJQRUtQdTM1ejZJNldGVkhaRjRsQVR4dWRodGJkM09xNzk2WmVrZ3h3ZXc?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQR2RDNU9TQWFnd2ZndjVkZGtzcHhMc0lhS2FqN1UxaWQxRm5zanR3SE5NUFJhSFQ2T0g5cFNabzJGUHJxZHloZFM3a0FCVXVaRF92Ukh6Z2dOdUlDeGpQZkswS3U2VUFteUxZcU1xYlJoSGFWVVB2RHZHby1pY2VyVFRDajVjN05RN0FyeG1lXzYycGJPcVBqWHZqZXJpQ1RUTlQyclRJNElLNENWQ2E1Ul9jdw?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to buy Crinetics for $10 billion in rare-diseases push", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOX3N1NDFzcDNMSmVSODY1SEJGRm51Sl96QmtwWV9zMHA3RUZTRVlDenhJaG01alZQSU5KZUNWV2NFMFp6c0U5Xy1aZFZ2UXVmNWFGNk1HR1NMcGpJWHVpQjVtQWV2Z0FqMldWWHFwMlA2cHh1eDBtT19sem9BZ1ljblQta09WbWdBcjFzX3JVY2h2WlFsQ1VZ?oc=5", "source_name": "Reuters", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeUVTekQtYjFqODVQTUpmWnpTSlBZT3lEWmhDVjhFZEc2dDctNjZXZ0MySENpa01tQS1CLVgtNTB6cGRWNWIyME9BOGhpRGlDYWF2bWYxRHlnbEtmN3FuZUlVT2c5NVhqZlNjSUlVTWxvYUFCX29xUU4wemRLYkhnOFhnOFhBVmJvYVk5Q1VfaW5KLWN0bElGRG9fdmlXZ1VpNjRqR3NTaWlqQVRCOHdLRkUzdTlLblNPOENJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYUJCRHpLdzhuNmcxVnZLVUVLSWc3U0JqNVpuOHNLbmMwZmE4NG1Yb2M3Xy1CMUk0T1hjM3VmeEpTV2xJMmVTX1BiMk5VOG93WS1TeG1fQ2NlYk44cHBfQzFTZ2U1UERQSHlYU2lDeG1SQzNMOVJyazRvSDdVZ0JuMUtMbGdSU2xVXzBuRjdDN2dwaUd5Y1pXdVQwZ3h2alFHb0k3ZE9CVUM?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock After Strong Multi\u2011Year Run Is The Price Still Reasonable", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVW9halB2RDE0V056SmV5NEd0Wl95ekI0eWM3QzVsckpLQ2RMWkF3SWRMSUFmMlViUHBObGVobXhwYW5CWU42WG5NUG45WHhDNGEzcHlheG1hM1lZWkpTOUs3UFFmUHdDOUw2V2tEV0N4YnlMY0d0cmswalo4WnZzTWlVZGd6ZmdyeW5WSXZJRFplSFkyRnREQnlJaVN4MFA3WS1uWU55blg?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPNzJydi1RUXhvaVExQVVJWnhpYjEyb3NOVHJheExOYmsyLU5famxjRnRWdS1TSDJLWjZNUmtEa3RLNkZxaGVtYWNPSmFLSFJnNktJWDVHSk9DVFlmVVdLLWRmWHdiR19LZXpWZm9MWlU4VkVOOGp0QktVX3ZmdWtiZ25BSS05SzVqaEtacm9fSGI4bzcyMVN0RTNIWWFCaTA?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQeUVIWEVWTFVLNWlzMWNvNjgzWUI4dEl6QUxLX203eER6UlF2SXBUSGR0WGRBUTh4ZjZEaW4wVFZyMElqZXVWbGlmd2hPWkc0WjNVMFVhcTdtbU1BU2VUMmdDOWQxeXkyMV9feWlhV2NKV0x5eEtzU0NSeUZmNFhqaWIxUkoxdVQ0YXN3VWtZRXZEWDk3eXI4ZjZueEtHc190NUlXTk13LVFNZ1gzUDdPMzAzOEprWWZ1WDdTNWEwTTBWS3Fu?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQY2F4dS1iZUJuTE1VNlVHQ1paVHg1U2VRUG5vcTZFdmFSdXB0Z0RQdVlkUXdxNzhYaGIzOVNhVWctVnJpUG1ZZFNydFkwUGo4Si1UdmtSaFNXb1RuQnNFdU1vekFEU3pGYVhwUnlvY01zdmJ6dXZrZ1Bia3ZDRHI4NGRCN1ZudnRWMkVYMzhleWp5OHpmdjJOdkRhVDJKYW9VMXE1dDV6dVhJQzR4aXI4?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPS0tESHdtOGhOSUhoZ3VTUUtOSXY0S3hLNzdNYmZMcmpMSTJVQkNpZDk2RzJDTEJJckdoNFZkR29zVGI3Vmh5OFV5cU5QNV80MFc1cjhyTlhKcFB2UG9MbkRoR2xZamR1NkNBQmhsRFRDYkQ1U21jLWpoMWE3bmxxT3BOY05vdjhWWmF0UXNGdjEyZE9TcjJYTlpfMnJOa2sxalJPT21rYWQ2d1JwZ0ZDa3pR?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPNWgxZmFPcUY5cHVqUjNNZ2pHVDE5Y0FJdnZBYmxLQlBKZnlGMC10UExaNUdzc0U1cWQxbmVKa1gzekFIazRWN3RsTTFKTGU0bURmV0dSbFVvVllDQS1mNnprR3lGQUxEQnNLR1FPWWhVdDZOVE9fRWZ4THNNQzdoUnk3ajg4amROUE9oUXBzWDFRUjg5N3c5ZzZ4S1NoeEkyNFY1OWVkQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR3pDcWtZWjd1c1dwOTlpY0cwZUJkYWJCLVBlS0o0Y0ctOE5ENUh5b2dicHhSdGxmR19XblF0UzgtQkVaOTM1ZnFGcl85bS1DMGYtRzI5bTZwMVByeWs5YmVYcVR5elM4cjVHVmQ3aHpHWlRScUFKRWxtUVl3c3lhcFpndWt5MlVJY0xpdUpiRkNsUk84U3kyVHZLT2tPT3F5am40bE9YWFA?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdXIxTVd1ZHVTWmF3Tk55OHVsWW1aa204VXlzNkZuQWpfaGJkRjhlRncxRkZUb2ctYlJLV1hiY0QxYlFzMW9OS1A1WjlzaDhrclNGZUtXZ1gyRVNaTDRkUi1PcjBnVTBiVnpFaGdQWVBDRjh6b2FNZVNHcndESkNydFByQWVVTE9yU2RoUnZMSTFVdGdNakt0TlpoNXg5SnRDaWZSMUprbw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals Successfully Diversifying Beyond Cystic Fibrosis", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQQ21BWXcycGhEUHoxYXBOcWk0eWJTYVlWcHpYd2dEMHZqaEJ4R1ZTM0RYQ2ZmOWRSUHlGNC15U3dRSXQ3VjA0V1dBTW5sVE92MmFEZEdwelRvREhfalpLVjI2YnNMUlU4eUJGYVhTNF9DMi1yX3RfME9CVkxkenViWHJvbWs0QUNmbnRjWVhMZjZzelRzQVhGV05EdHBkVzNPLVhFSDBYM1JGU2pGcVE?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-27T21:19:59+00:00", "published_display": "27 Feb 2026 21:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMUxjTEUwRWhBQmxlYXlaVTRqY1NuMEFpX0pFR3ltQmVnVXUwdEtFbEhoUkswZ1NoYW5QbVhSUTM3anpxclI5d2NzSlIwSjg1a0d6cGdOTUg4ZEF3U0IyN0NtLUg2eGxucldIajMzN1lIaFFmNnprWlFYZWRSdjVpaHVPYW0xOWhUdmhv?oc=5", "source_name": "Time Magazine", "published_at": "2026-01-07T17:42:38+00:00", "published_display": "07 Jan 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex\u2019s Journavx successor culled in acute pain after falling short in Phase II", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNTlp6QlZMM09CSTNhd1FHUXZocTc1NnJjbEllbkNjb2VDRlN0dV91Z2ZJUHc3MUt5aUt6TjZ2eVF5bmhGTi1JMVR6a0xVVlpTZmJ0TjZDRUVQRnN5S0F3RDJ5SVY3Q3JTRFdCbUVJelk2MzNkRDVIbExYSjdjN1hmSy1GaGl1dFpFT3hWalZKQjBaOVA4SHZR?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxOaGw3ZzNKZThYbDM5LURlSXlaYTRsSG01Z25CS2R3TE16ZEViR3ZMUjZwY1ZBREhpc1poaUlmNGlsbXV6alZLZEQ0U2l3WWdQdlFXOEE4N21ialRuN1d5VWlnMzRwVkt4NlNaU2NJdkhQWlIxWElBMXMyb0JhTTJiX0lwalZNQklCYzRPY3ZpNm1VODZpT1BCY1FtQzNhRXNyUENDaWtOQ0JROEdWdFBGVEpvTFFZeFZLai1QR2swUzQtLXZMOVNpTmxRajdpVFhybVViVnpDd2F2dmkxY0xtZXJmV29sNUlFWWQtX1kyV1V4b2d6OGI1V0RFZ3hjQkZPRTBuVDg4SjBzUW04M1pjREVYX190STdrbllwbWVObDMxU3c?oc=5", "source_name": "PR Newswire Canada", "published_at": "2025-07-22T07:00:00+00:00", "published_display": "22 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Non Opioid Drug Painkiller Stock Fda Journavx", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQeERmRVBhdm4xa1I2cHZmeUJkeERUUWxodE1HZ1EyLU1yM08zdUlEV2x2WWNaZjN2VUtIdG12YzVoUzIyWGJqSl90cmllTlZadDMwcjBjODhCWnpESzBORGdmZUVfMUZTR09WMmRNNEI5cFRJQUdsQ0daZEdwemZPbFpkbU4?oc=5", "source_name": "qz.com", "published_at": "2025-01-31T08:00:00+00:00", "published_display": "31 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prediction: Vertex Pharmaceuticals (VRTX) Could Be The Next Stock Split Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNZ0JCcndyUmhwZTJNVGNNU0pjdkJiU1FId1o1VzZnQXBwVHpYQnBTY3lWX0RQeFU5TWdhYXZPenQ2Tmx1TXZzVWF4TzR5QmpxZ0VWdDctSWx0aGFjUXdTdUdKOXU5S3p5TXk1UC1Jek9hQnJJM2VQLUlfMzZ6eUQwZnU0OGlzVlZyNjRRaXZLSkRBblVDWDhoTXJzRFlLOTJIZV9mZVdCNTJMc2xEWF81TG5pSHlRX2h1SFE?oc=5", "source_name": "24/7 Wall St.", "published_at": "2024-10-31T07:00:00+00:00", "published_display": "31 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 31, "sentiment_summary": {"positive": 12, "negative": 2, "neutral": 17, "score": 56, "total": 31, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 15.0, "count": 26}, {"event": "deals", "label": "Deals and strategy", "weight": 2.55, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 8319.0, "latest_week": "2026-07-17", "one_week_move": -2.5, "four_week_move": 6.7, "twelve_week_move": 9.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.106864, "market_dynamics_buy_signal": false, "relative_strength": 2.81533, "fair_value_gap": 3.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.871, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.5% over one week, +6.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 68, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 11}, {"label": "simplywall.st", "count": 2}, {"label": "MSN", "count": 2}, {"label": "Trefis", "count": 2}, {"label": "24/7 Wall St.", "count": 2}, {"label": "ChartMill", "count": 1}, {"label": "AOL.com", "count": 1}, {"label": "Bloomberg.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 31}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Deals and strategy", "count": 4}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "31", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.5% over one week, +6.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation"}], "updated_at": "2026-07-21T19:33:34.327094+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}